🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Game WON ✅💙👏

We have started! Chris Booth kicking off the CSO workshop with a background on what CSO is and why we exist.

Presented at #ASCO25: A 3-year structured exercise program after adjuvant chemotherapy for colon cancer improved disease-free and overall survival, physical functioning, and fitness, as compared with health education alone. Full CHALLENGE phase 3 trial results:

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer | New England Journal of Medicine ⁦OncoAlert⁩ #ASCO25 nejm.org/doi/full/10.10…

Results of #CHALLENGE #RCT clear: ✅ people need structured exercise support to increase exercise after colon cancer treatment ⬆️survival ⬇️colon cancer recurrence We need to do more than just tell people to exercise. Structured exercise create lifelong change #ASCO25 #CRCSM

Meet Cherrie, one of the earliest participants in the CHALLENGE trial, and my colleague Janette Vardy talking about what these results mean. 9news.com.au/videos/nationa…

Join us for a special CSO webinar on June 19 where we discuss some important takeaways from #ASCO25, CSO style. Registration link: queensu.zoom.us/meeting/regist…

Important findings from Journal of Clinical Oncology on systemic anticancer treatments at EOL Camilla Zimmermann MD PhD 📊 KEY FINDINGS from 68,963 cancer patients: 26.6% received systemic therapy in last 30 days of life Immunotherapy use at EOL ⬆️ significantly ascopubs.org/doi/10.1200/JC…

"Our desire not to be inferior to others in terms of performance, combined with the idea that we can freely choose to go the extra mile, can lead to self-exploitation. We force ourselves to go beyond what is good for us — until we burn out." - Berend van der Kolk (The Quantified Society)

🎓 #PhD #Scholarship Opportunity! Join the The Daffodil Centre Triple I (Innovation, Implementation, Impact) team & help shape the future of cancer control. 🌟 Work at the intersection of #CancerResearch & real-world impact. 📅 DM ASAP for more info daffodilcentre.org/streams/triple… #ImpSci

Absolutely wild explanation for the prognostic impact of perineural invasion across solid malignancies. 🤯

MOGA welcomes new members to the 2025 YOGA Committee. The YOGA Committee plays a vital role in representing young oncologists across Australia, fostering peer support, education, mentorship, and advocacy. More > moga.org.au/all-news/moga-… ausyoungoncs

Congratulations to the incoming new YOGA National Committee Members! Following a competitive selection process, the following Young Oncologist Members have been elected to the Committee: moga.org.au/all-news/moga-…

ADOPT-lung TiP paper out in Lung Cancer Journal doi.org/10.1016/j.lung… Neo-adjuvant nivolumab has shown sig. OS benefit in CheckMate-816. The need for 1 additional year of adjuvant immunotherapy is being debated. This trial aims to investigate the added value of adjuvant durvalumab

The behaviour of US pharmaceutical companies in lobbying the US govt to undermine our PBS is outrageous. It's the worst kind of bad corporate citizen. Reputability clearly matters not. #cancer #cancerdrugs #pbs abc.net.au/news/2025-07-0…

An incredibly important clinical trial. Our site (Nepean Hospital) has recruited one wonderful individual so far!

Dear world Introducing the newest South Sydney Rabbitohs 🐰 supporter. Bishal Gyawali, MD, PhD, FASCO is coming in at an awkward time but he is already dedicated for life #sstid

Onco bunnies. Dr Deme Karikios Martin Stockler

Thank you #anzup25 for the opportunity to present our work on rethinking the role of physical examination in active surveillance programs for men with stage 1 testicular cancer

While phase 3 oncology trials frequently report success based on alternative endpoints, actual enhancements in overall survival and quality of life are uncommon. ja.ma/4m3Eesv Alexander Sherry Bishal Gyawali, MD, PhD, FASCO Pavlos Msaouel Ethan Ludmir MD